Maggie Chon U Cheang

9PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).

Holly Tovey, Orsolya Sipos, Joel S Parker

|Sep 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.

Patrycja Gazinska, Charlotte Milton, Jacopo Iacovacci

|Dec 30, 2021
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.

Milana A Bergamino, Gabriele Morani, Joel Parker

|Oct 14, 2021
Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer.

Mitch Dowsett, Lucy Kilburn, Mothaffar F Rimawi

|Sep 10, 2021
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler.

Helga Bergholtz, Jodi M Carter, Alessandra Cesano

|Feb 12, 2021
Lights and Shadows in Immuno-Oncology Drug Development.

Milana Bergamino Sirvén, Sonia Pernas, Maggie C U Cheang

Pageof 2